Drug-eluting stent thrombosis in patients undergoing non-cardiac surgery: Is it always a problem?

British Journal of Anaesthesia

Volumn 100, Issue 4, 2008, Pages 472-477

  Godet, G ^a,b   Le Manach, Y ^a   Lesache, F ^a   Perbet, S ^a   Coriat, P ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Cardiac troponin I; Complications, myocardial infarction; Coronary artery disease; Drug eluting stents; Surgery, non cardiac

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FLURBIPROFEN; LOW MOLECULAR WEIGHT HEPARIN; ANTICOAGULANT AGENT; TROPONIN I;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; DRUG ELUTING STENT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROTEIN SECRETION; REVASCULARIZATION; VASCULAR SURGERY; BLOOD; BLOOD VESSEL PROSTHESIS; CORONARY ARTERY DISEASE; DRUG ADMINISTRATION; ELECTROCARDIOGRAPHY; METHODOLOGY; MIDDLE AGED; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD VESSEL PROSTHESIS; CORONARY DISEASE; CORONARY THROMBOSIS; DRUG ADMINISTRATION SCHEDULE; DRUG-ELUTING STENTS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; RISK ASSESSMENT; TROPONIN I;

EID: 41949087121     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aen033     Document Type: Article

References (25)

1. Fleron MH, Dupuis M, Mottet P, Le Feuvre C, Godet G. Non cardiac surgery in patient with coronary stenting: think sirolimus now! Ann Fr Anesth Reanim 2003; 22: 733-5
2. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364: 1519-21
3. Murphy JT, Fahy BG. Thrombosis of sirolimus-eluting coronary stent in the post anesthesia care unit. Anesth Analg 2005; 101: 971-3
4. de Souza DG, Baum VC, Ballert NM. Late thrombosis of a drug-eluting stent presenting in the perioperative period. Anesthesiology 2007; 106: 1057-9
5. Kaluza GL, Joseph J, Lee JR, Raizner ME, Raizner AE. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000; 35: 1288-94
6. Wilson SH, Fasseas P, Orford JL, et al. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 2003; 42: 234-40
7. Grines CL, Bonow RO, Casey DE Jr, et al. American Heart Association; American College of Cardiology; Society for Cardiovascular Angiography and Interventions; American College of Surgeons; American Dental Association; American College of Physicians. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 2007; 115: 813-8
8. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2007; 116: e418-99
9. Vicenzi MN, Meislitzer T, Heitzinger B, Halaj M, Fleisher LA, Metzler H. Coronary artery stenting and non-cardiac surgery - a prospective outcome study. Br J Anaesth 2006; 96: 686-93
10. Albaladejo P, Marret E, Piriou V, et al. Management of oral antiplatelet treatment for patients with coronary stents. Ann Fr Anesth Reanim 2006; 25: 796-8
11. Albaladejo P, Marret E, Piriou V, Samama CM. Perioperative management of antiplatelet agents in patients with coronary stents: recommendations of a French task Force. Br J Anaesth 2006; 97: 580-5
12. Luepker RV, Apple FS, Christenson RH, et al. AHA Council on Epidemiology Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 2003; 108: 2543-9
13. Perin EC. Choosing a drug-eluting stent: a comparison between CYPHER and TAXUS. Rev Cardiovasc Med 2005; 6: S13-21
14. Rogers CDK. Drug-eluting stents: clinical perspectives on drug and design differences. Rev Cardiovasc Med 2005; 6: S3-12
15. Goy JJ, Stauffer JC, Siegenthaler M, Benoit A, Seydoux C. A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology: the TAXi trial. J Am Coll Cardiol 2005; 45: 308-11
16. Morice MC, Colombo A, Meier B, et al. REALITY Trial Investigators. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. JAMA 2006; 295: 937-8
17. Charbucinska KN, Godet G, Itani O, et al. Anticoagulation management for patients with drug-eluting stents undergoing vascular surgery. Anesth Analg 2006; 103: 261-3
18. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007; 356: 998-1008
19. Moreno R, Fernandez C, Hernandez R, et al. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005; 45: 954-9
20. Hong MK, Mintz GS, Lee CW, and , et al. Asian Paclitaxel-Eluting Stent Clinical Trial. Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT). Circulation 2003; 107: 517-20
21. Ong AT, Hoye A, Aoki J, et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 2005; 45: 947-53
22. Marcucci C, Chassot PG, Gardaz JP, et al. Fatal myocardial infarction after lung resection in a patient with prophylactic preoperative coronary stenting. Br J Anaesth 2004; 92: 743-7
23. Samama CM, Thiry D, Elalamy I, et al. Perioperative activation of hemostasis in vascular surgery patients. Anesthesiology 2001; 94: 74-8
24. Schouten O, van Domburg RT, Bax JJ, et al. Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol 2007; 49: 122-5
25. Howard-Alpe GM, De Bono J, Hudsmith L, Orr WP, Foex P, Sear JW. Coronary artery stents and non-cardiac surgery. Br J Anaesth 2007; 98: 560-74